Manufacturing and Production

Showing 15 posts of 5866 posts found.

ema_building_face_web

EU approves Pfizer-BioNTech vaccine for 12-15 year olds

June 1, 2021 Manufacturing and Production, Sales and Marketing

The EMA has approved the Pfizer-BioNTech COVID-19 vaccine for 12-15 year olds. Individual EU member states can now decide if …
1c64f360-c5ef-43b6-bcef-13cede36f571

Lucida Medical gains CE marking for AI prostate cancer tech

June 1, 2021 Manufacturing and Production AI, MRI, NHS, prostate cancer

Cambridge-based AI company, Lucida Medical, has received CE marking for its new machine learning-based prostate cancer detection software, Prostate Intelligence …
laboratory-testing-az

DMD study in vamorolone reports positive results

June 1, 2021 Manufacturing and Production

Santhera Pharmaceuticals and ReveraGen BioPharma have announced positive results from their Phase IIb VISION-DMD study, evaluating the efficacy and safety …
baby-2416718_1280

Five-month-old baby receives gene therapy Zolgensma on NHS

June 1, 2021 Manufacturing and Production, Sales and Marketing

A five-month-old baby is one of the first patients to receive Zolgensma, the world’s most expensive drug, on the NHS. …

FDA accepts Ipsen’s NDA for ultra-rare genetic disorder drug

June 1, 2021 Manufacturing and Production EMA, FDA, FOP, NDA, ipsen

The FDA have accepted Ipsen’s New Drug Application (NDA) for palovarotene, an oral, investigational, selective RARγ agonist for the prevention …

NICE recommends inducing woman in labour earlier than previously advised

May 25, 2021 Manufacturing and Production

In new draft guidance published today NICE has recommended that inducing women in labour earlier than previously advised will make …
takeda_usa_pharmaceuticals_u

Takeda: Dengue vaccine successful in long-term trials & set for global distribution

May 25, 2021 Manufacturing and Production EMA, Vaccine, dengue

Japanese pharma company Takeda has announced long-term safety and efficacy results for its dengue vaccine candidate, TAK-003, and has successfully …

Man’s eyesight partially restored with optogenetic therapy

May 25, 2021 Manufacturing and Production

A man in France has had his eyesight restored after 20 years of complete blindness, in the first reported case …

New research begins on producing HIV treatments in plants

May 25, 2021 Manufacturing and Production

St George’s, University of London has announced a partnership with Leaf Expression Systems to produce HIV treatments in plants. The …

CMA to review AstraZeneca’s $39 billion buyout of Alexion

May 25, 2021 Manufacturing and Production

The UK’s Competition and Markets Authority (CMA) is to review AstraZeneca’s $39 billion buyout of US-based Alexion Pharmaceuticals. The COVID-19 …

AI software assists in radiographic fracture detection

May 18, 2021 Manufacturing and Production

GLEAMER’s BoneView, an artificial intelligence system, when combined with health professionals’ interpretations, lowered the false negative rate (undetected fractures) on …

Sandoz announces €150 million investment in antibiotic production

May 18, 2021 Manufacturing and Production EU, manufacturing, production

Sandoz, a division of Novartis, has announced plans to develop its European antibiotics manufacturing network by expanding the production capabilities …
pexels-lucy-6816451_cropped

Asthma drug Dupixent sees positive results in child trials

May 18, 2021 Manufacturing and Production FDA, asthma

Data presented at the 2021 American Thoracic Society International Conference from a Phase III trial of Dupixent (dupilumab) in children …

Pfizer-BioNTech vaccine can be kept in fridge longer than previously thought

May 18, 2021 Manufacturing and Production

The EMA has extended the recommended approved storage period for an unopened thawed vial of the Pfizer-BioNTech vaccine from five …

Major UK study finds 96% people develop antibodies after one COVID-19 jab

May 18, 2021 Manufacturing and Production

More than 96% of people develop antibodies after just one COVID-19 jab of either AstraZeneca or Pfizer, and almost 100% …
The Gateway to Local Adoption Series

Latest content